Dendritic cells pulsed with antigen-specific apoptotic bodies prevent experimental type 1 diabetes

Clinical and Experimental Immunology

Volumn 160, Issue 2, 2010, Pages 207-214

  Marin Gallen, S ^a   Clemente Casares, X ^a   Planas, R ^a   Pujol Autonell, I ^a   Carrascal, J ^b   Carrillo, J ^a   Ampudia, R ^a   Verdaguer, J ^b   Pujol Borrell, R ^a   Borras F E ^a   Vives Pi, M ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Apoptosis; Autoimmunity; Dendritic cells; NOD mice; Tolerance

Indexed keywords

BETA INTERFERON; CD40 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; AUTOLOGOUS HEMATOPOIETIC DENDRITIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BONE MARROW; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET BETA CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK REDUCTION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; AUTOANTIGENS; CELLS, CULTURED; CYTOPLASMIC VESICLES; DENDRITIC CELLS; DIABETES MELLITUS, TYPE 1; ENDOCYTOSIS; EPITOPES; FEMALE; IMMUNE TOLERANCE; IMMUNOTHERAPY; INSULIN-SECRETING CELLS; INTERFERON-BETA; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; RECOMBINANT FUSION PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 77950637110     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.04082.x     Document Type: Article

References (28)

1. Bach JF, Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu Rev Immunol 2001 19 : 131 161.
2. Durant S, Alves V, Coulaud J, Homo-Delarche F. Nonobese diabetic (NOD) mouse dendritic cells stimulate insulin secretion by prediabetic islets. Autoimmunity 2002 35 : 449 455.
3. Vasquez AC, Feili-Hariri M, Tan RJ, Morel PA. Qualitative and quantitative abnormalities in splenic dendritic cell populations in NOD mice. Clin Exp Immunol 2004 135 : 209 218.
4. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 252.
5. Clare-Salzler MJ, Brooks J, Chai A, Van Herle K, Anderson C. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest 1992 90 : 741 748.
6. Lutz MB, Suri RM, Niimi M et al. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur J Immunol 2000 30 : 1813 1822.
7. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994 179 : 1109 1118.
8. Lo J, Clare-Salzler MJ. Dendritic cell subsets and type 1 diabetes: focus upon DC-based therapy. Autoimmun Rev 2006 5 : 419 423.
9. Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol 2007 7 : 964 974.
10. Steinman RM, Turley S, Mellman I, Inaba K. The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med 2000 191 : 411 416.
11. Alba A, Puertas MC, Carrillo J et al. IFN beta accelerates autoimmune type 1 diabetes in nonobese diabetic mice and breaks the tolerance to beta cells in nondiabetes-prone mice. J Immunol 2004 173 : 6667 6675.
12. Hamaguchi K, Gaskins HR, Leiter EH. NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse. Diabetes 1991 40 : 842 849.
13. Aaronson SA, Todaro G. Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J Cell Physiol 1968 72 : 141 148.
14. Morelli AE, Larregina AT, Shufesky WJ et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 2003 10 : 611 620.
15. Strid J, Lopes L, Marcinkiewicz J Petrovska L, Nowak B, Chain BM, Lund T. A defect in bone marrow derived dendritic cell maturation in the nonobese diabetic mouse. Clin Exp Immunol 2001 123 : 375 381.
16. Feili-Hariri M, Dong X, Alber SM, Watkins SC, Salter RD, Morel PA. Immunotherapy of NOD mice with bone marrow-derived dendritic cells. Diabetes 1999 48 : 2300 2308.
17. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol 2008 8 : 279 289.
18. Hugues S, Mougneau E, Ferlin W et al. Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic ß cells. Immunity 2002 16 : 169 181.
19. Xia CQ, Peng R, Qiu Y, Annamalai M, Gordon D, Clare-Salzler MJ. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice. Diabetes 2007 56 : 2116 2123.
20. Wang Z, Shufesky WJ, Montecalvo A, Divito SJ, Larregina AT, Morelli AE. In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS ONE 2009 4 : e4940.
21. Ohnmacht C, Pullner A, King SB et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous autoimmunity. J Exp Med 2009 206 : 549 559.
22. Fujii S, Liu K, Smith C, Bonito AJ, Steinman RM. The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 2004 199 : 1607 1618.
23. Ma L, Qian S, Liang X et al. Prevention of diabetes in NOD mice by administration of dendritic cells deficient in nuclear transcription factor-kappaB activity. Diabetes 2003 52 : 1976 1985.
24. Machen J, Harnaha J, Lakomy R, Styche A, Trucco M, Giannoukakis N. Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells. J Immunol 2004 173 : 4331 4341.
25. Shoda LK, Young DL, Ramanujanm S et al. A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 2005 23 : 115 126.
26. Chatenoud L, Primo J, Bach JF. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J Immunol 1997 158 : 2947 2954.
27. Ulaeto D, Lacy PE, Kipnis DM, Kanagawa O, Unanue ERA. T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant. Proc Natl Acad Sci USA 1992 89 : 3927 3931.
28. Vija L, Farge D, Gautier J et al. Mesenchymal stem cells: stem cell therapy perspectives for type 1 diabetes. Diabetes Metab 2009 35 : 85 93.